Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities
Cardiac fibrosis is a common pathophysiologic process in nearly all forms of heart disease which refers to excessive deposition of extracellular matrix proteins by cardiac fibroblasts. Activated fibroblasts are the central cellular effectors in cardiac fibrosis, and fibrotic remodelling can cause se...
Main Authors: | Ruiqiang Qi, E. Lin, Juan Song, Yan Wang, Ling Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/24/8784 |
Similar Items
-
Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis
by: Maria Raquel Moita, et al.
Published: (2022-12-01) -
Exploring the cardiac ECM during fibrosis: A new era with next-gen proteomics
by: Vivek Sarohi, et al.
Published: (2022-11-01) -
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
by: Xiaoying Yin, et al.
Published: (2023-03-01) -
Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair
by: Luke R. Perreault, et al.
Published: (2024-02-01) -
Understanding fibrosis: Mechanisms, clinical implications, current therapies, and prospects for future interventions
by: Jennifer C. Ku, et al.
Published: (2024-06-01)